Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 4
2010 4
2011 4
2012 5
2013 3
2014 1
2016 1
2017 2
2018 2
2020 6
2021 21
2022 19
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.
Attini R, Cabiddu G, Ciabatti F, Montersino B, Carosso AR, Gernone G, Gammaro L, Moroni G, Torreggiani M, Masturzo B, Santoro D, Revelli A, Piccoli GB; Italian Society of Nephrology’s Project Group on Kidney and Pregnancy. Attini R, et al. Among authors: torreggiani m. J Nephrol. 2024 May 9. doi: 10.1007/s40620-024-01980-1. Online ahead of print. J Nephrol. 2024. PMID: 38724876 No abstract available.
Hypertension and Proteinuria in a Pregnancy: A Quiz.
Torreggiani M, Stancanelli MR, Njandjo L, Fois A, Piccoli GB. Torreggiani M, et al. Am J Kidney Dis. 2024 May;83(5):A17-A18. doi: 10.1053/j.ajkd.2023.10.019. Am J Kidney Dis. 2024. PMID: 38643986 No abstract available.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Roadmaps to green nephrology: a mediterranean point of view.
Ben Hmida M, Torreggiani M, Berman-Parks N, Salomone M, Piccoli GB. Ben Hmida M, et al. Among authors: torreggiani m. Curr Opin Nephrol Hypertens. 2024 Jan 1;33(1):115-121. doi: 10.1097/MNH.0000000000000943. Epub 2023 Nov 2. Curr Opin Nephrol Hypertens. 2024. PMID: 37916609 Review.
86 results